Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4
The key question is not which peptide is "better." It is which peptide produces the best outcome for your specific situation, tolerability profile, and research goals
Thats the implication of a new study that examined health records of people with type 2 diabetes and opioid use disorder
If youre currently taking a GLP-1, such as Ozempic, and trying to conceive, its important you talk to your healthcare provider as they can guide you through this process
A muscular athlete and an inactive person with high body fat can have identical BMIs despite very different health profiles
The FDA has stated that compounded medications are not FDA-approved and are not the same regulatory category as approved generic drugs